These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 7898773

  • 1. Competitive antagonism of serotonin (5-HT)2C and 5-HT2A receptor-mediated phosphoinositide (PI) turnover by clozapine in the rat: a comparison to other antipsychotics.
    Canton H, Verrièle L, Millan MJ.
    Neurosci Lett; 1994 Nov 07; 181(1-2):65-8. PubMed ID: 7898773
    [Abstract] [Full Text] [Related]

  • 2. Regulation of serotonin 5-HT2C receptors in the rat choroid plexus after acute clozapine treatment.
    Kuoppamäki M, Seppälä T, Syvälahti E, Hietala J.
    Eur J Pharmacol; 1994 Oct 14; 269(2):201-8. PubMed ID: 7851496
    [Abstract] [Full Text] [Related]

  • 3. Differential regulation of rat 5-HT2A and 5-HT2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs.
    Kuoppamäki M, Pälvimäki EP, Hietala J, Syvälahti E.
    Neuropsychopharmacology; 1995 Oct 14; 13(2):139-50. PubMed ID: 8597525
    [Abstract] [Full Text] [Related]

  • 4. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ, Gobert A, Newman-Tancredi A, Audinot V, Lejeune F, Rivet JM, Cussac D, Nicolas JP, Muller O, Lavielle G.
    J Pharmacol Exp Ther; 1998 Sep 14; 286(3):1341-55. PubMed ID: 9732398
    [Abstract] [Full Text] [Related]

  • 5. Generalization of clozapine as compared to other antipsychotic agents to a discriminative stimulus elicited by the serotonin (5-HT)2A antagonist, MDL100,907.
    Dekeyne A, Iob L, Millan MJ.
    Neuropharmacology; 2003 Apr 14; 44(5):604-15. PubMed ID: 12668046
    [Abstract] [Full Text] [Related]

  • 6. Antagonist properties of the novel antipsychotic, S16924, at cloned, human serotonin 5-HT2C receptors: a parallel phosphatidylinositol and calcium accumulation comparison with clozapine and haloperidol.
    Cussac D, Newman-Tancredi A, Nicolas JP, Boutin JA, Millan MJ.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 May 14; 361(5):549-54. PubMed ID: 10832610
    [Abstract] [Full Text] [Related]

  • 7. The serotonin 5-HT2C receptor is a prominent serotonin receptor in basal ganglia: evidence from functional studies on serotonin-mediated phosphoinositide hydrolysis.
    Wolf WA, Schutz LJ.
    J Neurochem; 1997 Oct 14; 69(4):1449-58. PubMed ID: 9326273
    [Abstract] [Full Text] [Related]

  • 8. In-vivo assessment of 5-HT2A and 5-HT2C antagonistic properties of newer antipsychotics.
    Sánchez C, Arnt J.
    Behav Pharmacol; 2000 Jun 14; 11(3-4):291-8. PubMed ID: 11103883
    [Abstract] [Full Text] [Related]

  • 9. Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT(2C) receptors in vivo.
    Di Matteo V, Cacchio M, Di Giulio C, Di Giovanni G, Esposito E.
    Pharmacol Biochem Behav; 2002 Apr 14; 71(4):607-13. PubMed ID: 11888552
    [Abstract] [Full Text] [Related]

  • 10. Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone.
    Schreiber R, Brocco M, Millan MJ.
    Eur J Pharmacol; 1994 Oct 13; 264(1):99-102. PubMed ID: 7530204
    [Abstract] [Full Text] [Related]

  • 11. Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT2A sites for PCP-induced locomotion in the rat.
    Millan MJ, Brocco M, Gobert A, Joly F, Bervoets K, Rivet J, Newman-Tancredi A, Audinot V, Maurel S.
    Eur J Neurosci; 1999 Dec 13; 11(12):4419-32. PubMed ID: 10594669
    [Abstract] [Full Text] [Related]

  • 12. Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist but not antagonist binding to 5-HT2c receptors after chronic treatment.
    Hietala J, Kuonnamäki M, Pälvimäki EP, Laakso A, Majasuo H, Syvälahti E.
    Psychopharmacology (Berl); 2001 Sep 13; 157(2):180-7. PubMed ID: 11594443
    [Abstract] [Full Text] [Related]

  • 13. Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors.
    Herrick-Davis K, Grinde E, Teitler M.
    J Pharmacol Exp Ther; 2000 Oct 13; 295(1):226-32. PubMed ID: 10991983
    [Abstract] [Full Text] [Related]

  • 14. Limited participation of 5-HT(1A) and 5-HT(2A/2C) receptors in the clozapine-induced Fos-protein expression in rat forebrain regions.
    Sebens JB, Kuipers SD, Koch T, Ter Horst GJ, Korf J.
    Eur J Pharmacol; 2000 Nov 10; 408(1):11-7. PubMed ID: 11070178
    [Abstract] [Full Text] [Related]

  • 15. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
    Ichikawa J, Kuroki T, Dai J, Meltzer HY.
    Eur J Pharmacol; 1998 Jun 19; 351(2):163-71. PubMed ID: 9686999
    [Abstract] [Full Text] [Related]

  • 16. Atypical neuroleptics enhance histamine turnover in brain via 5-Hydroxytryptamine2A receptor blockade.
    Morisset S, Sahm UG, Traiffort E, Tardivel-Lacombe J, Arrang JM, Schwartz JC.
    J Pharmacol Exp Ther; 1999 Feb 19; 288(2):590-6. PubMed ID: 9918563
    [Abstract] [Full Text] [Related]

  • 17. 5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.
    Ichikawa J, Dai J, Meltzer HY.
    Brain Res; 2002 Jun 07; 939(1-2):34-42. PubMed ID: 12020849
    [Abstract] [Full Text] [Related]

  • 18. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R, Brocco M, Audinot V, Gobert A, Veiga S, Millan MJ.
    J Pharmacol Exp Ther; 1995 Apr 07; 273(1):101-12. PubMed ID: 7714755
    [Abstract] [Full Text] [Related]

  • 19. Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor.
    Rauser L, Savage JE, Meltzer HY, Roth BL.
    J Pharmacol Exp Ther; 2001 Oct 07; 299(1):83-9. PubMed ID: 11561066
    [Abstract] [Full Text] [Related]

  • 20. Chronic clozapine treatment decreases 5-hydroxytryptamine1C receptor density in the rat choroid plexus: comparison with haloperidol.
    Kuoppamäki M, Seppälä T, Syvälahti E, Hietala J.
    J Pharmacol Exp Ther; 1993 Mar 07; 264(3):1262-7. PubMed ID: 8383744
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.